While it is known that activation of this energy sensor inhibits cancer cell proliferation and growth through inhibition of anabolic processes, AMPK activation can confer cancer cell plasticity to survive under metabolic stress such as hypoxia and glucose deprivation, which are commonly observed in fast growing tumors. This evidence concerns the gene PRKAA2 and cancer.